• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2020 年澳大利亚昆士兰州采取 COVID-19 限制措施后,基因型多样性下降。

Decreased genotypic diversity following COVID-19 restrictions in Queensland, Australia 2020.

机构信息

Faculty of Medicine, Centre for Clinical Research, The University of Queensland, Brisbane, QLD, Australia.

Faculty of Pharmacy, Taibah University, Madinah, Saudi Arabia.

出版信息

Epidemiol Infect. 2023 Apr 13;151:e67. doi: 10.1017/S0950268823000523.

DOI:10.1017/S0950268823000523
PMID:37045547
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10154642/
Abstract

We investigated the potential effects of COVID-19 public health restrictions on the prevalence and distribution of (NG) genotypes in our Queensland isolate population in the first half of the year 2020. A total of 763 NG isolates were genotyped to examine gonococcal strain distribution and prevalence for the first 6 months of 2020, with 1 January 2020 to 31 March 2020 classified as 'pre' COVID-19 restrictions ( = 463) and 1 April 2020 to 30 June 2020 classified as 'post' COVID-19 restrictions ( = 300). Genotypes most prevalent 'pre' restrictions remained proportionally high 'post' restrictions, with some significantly increasing 'post' restrictions. However, genotype diversity was significantly reduced 'post' restrictions. Overall, it seems public health restrictions (9-10 weeks) were not sufficient to affect rates of infection or reduce the prevalence of well-established genotypes in our population, potentially due to reduced access to services or health-seeking behaviours.

摘要

我们调查了 COVID-19 公共卫生限制对 2020 年上半年昆士兰州分离株人群中 (NG) 基因型流行和分布的潜在影响。总共对 763 个 NG 分离株进行了基因分型,以检查淋病奈瑟菌菌株的分布和 2020 年前 6 个月的流行率,其中 2020 年 1 月 1 日至 3 月 31 日被归类为“前” COVID-19 限制(= 463),2020 年 4 月 1 日至 6 月 30 日被归类为“后” COVID-19 限制(= 300)。“前”限制中最流行的基因型在“后”限制中仍然保持相对较高的比例,其中一些基因型在“后”限制中显著增加。然而,“后”限制中基因型的多样性显著降低。总体而言,公共卫生限制(9-10 周)似乎不足以影响感染率或降低我们人群中既定基因型的流行率,这可能是由于服务减少或寻求健康行为。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f4d/10154642/df83e8f82ea3/S0950268823000523_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f4d/10154642/df83e8f82ea3/S0950268823000523_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f4d/10154642/df83e8f82ea3/S0950268823000523_fig1.jpg

相似文献

1
Decreased genotypic diversity following COVID-19 restrictions in Queensland, Australia 2020.2020 年澳大利亚昆士兰州采取 COVID-19 限制措施后,基因型多样性下降。
Epidemiol Infect. 2023 Apr 13;151:e67. doi: 10.1017/S0950268823000523.
2
Analysis of Neisseria gonorrhoeae susceptibility trends (MIC creep) from North India: A 15-years' experience!印度北部淋病奈瑟菌药敏趋势(MIC 漂移)分析:15 年经验!
Indian J Dermatol Venereol Leprol. 2025 Jul-Aug;91(4):432-439. doi: 10.25259/IJDVL_1096_2024.
3
High rates of Treponema pallidum, Neisseria gonorrhoeae, Chlamydia trachomatis, or Trichomonas vaginalis co-infection in people with HIV: a systematic review and meta-analysis.HIV感染者中梅毒螺旋体、淋病奈瑟菌、沙眼衣原体或阴道毛滴虫的高合并感染率:一项系统评价和荟萃分析。
Eur J Clin Microbiol Infect Dis. 2025 Jan;44(1):1-15. doi: 10.1007/s10096-024-04966-w. Epub 2024 Oct 28.
4
Effect of a community-based intervention for sexually transmitted infections on population-level prevalence among youth in Zimbabwe (STICH): a cluster-randomised trial.基于社区的性传播感染干预措施对津巴布韦青年人群患病率的影响(STICH):一项整群随机试验
Lancet Glob Health. 2025 Jan;13(1):e134-e145. doi: 10.1016/S2214-109X(24)00373-5. Epub 2024 Nov 14.
5
Antimicrobial Resistance of Neisseria Gonorrhoeae in a Newly Implemented Surveillance Program in Uganda: Surveillance Report.淋病奈瑟菌在乌干达新实施的监测项目中的抗药性:监测报告。
JMIR Public Health Surveill. 2020 Jun 10;6(2):e17009. doi: 10.2196/17009.
6
Review of mathematical models of Neisseria gonorrhoeae vaccine impact: Implications for vaccine development.淋病奈瑟菌疫苗影响的数学模型综述:对疫苗研发的启示
Vaccine. 2024 Jul 25;42(19S1):S70-S81. doi: 10.1016/j.vaccine.2024.03.068. Epub 2024 Mar 30.
7
Rapid expansion of Neisseria gonorrhoeae ST7827 clone in Australia, with variable ceftriaxone phenotype unexplained by genotype.澳大利亚淋病奈瑟菌 ST7827 克隆的快速扩张,其头孢曲松表型的变化无法用基因型解释。
J Antimicrob Chemother. 2023 Sep 5;78(9):2203-2208. doi: 10.1093/jac/dkad221.
8
The potential impact of a vaccine on Neisseria gonorrhoeae prevalence among heterosexuals living in a high prevalence setting.疫苗对高流行地区异性恋人群中淋病奈瑟菌流行率的潜在影响。
Vaccine. 2023 Aug 31;41(38):5553-5561. doi: 10.1016/j.vaccine.2023.07.048. Epub 2023 Jul 28.
9
Home-based versus clinic-based specimen collection in the management of Chlamydia trachomatis and Neisseria gonorrhoeae infections.沙眼衣原体和淋病奈瑟菌感染管理中家庭样本采集与门诊样本采集的比较
Cochrane Database Syst Rev. 2015 Sep 29;2015(9):CD011317. doi: 10.1002/14651858.CD011317.pub2.
10
The gonococcal vaccine candidate antigen NGO1701 is a periplasmic copper storage protein.淋病奈瑟菌疫苗候选抗原NGO1701是一种周质铜储存蛋白。
bioRxiv. 2025 May 7:2025.05.01.651437. doi: 10.1101/2025.05.01.651437.

引用本文的文献

1
Longitudinal genomic analysis of Neisseria gonorrhoeae transmission dynamics in Australia.澳大利亚淋病奈瑟菌传播动态的纵向基因组分析。
Nat Commun. 2024 Sep 14;15(1):8076. doi: 10.1038/s41467-024-52343-0.

本文引用的文献

1
Australian Gonococcal Surveillance Programme: 1 April to 30 June 2020.澳大利亚淋球菌监测项目:2020年4月1日至6月30日。
Commun Dis Intell (2018). 2020 Sep 15;44. doi: 10.33321/cdi.2020.44.74.
2
Australian Gonococcal Surveillance Programme, 1 January to 31 March 2020.澳大利亚淋球菌监测项目,2020年1月1日至3月31日。
Commun Dis Intell (2018). 2020 Jul 15;44. doi: 10.33321/cdi.2020.44.61.
3
Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016.淋病、衣原体、滴虫病和梅毒:2016 年全球流行率和发病率估计值。
Bull World Health Organ. 2019 Aug 1;97(8):548-562P. doi: 10.2471/BLT.18.228486. Epub 2019 Jun 6.
4
Emergence and spread of ciprofloxacin-resistant Neisseria gonorrhoeae in New South Wales, Australia: lessons from history.澳大利亚新南威尔士州出现并传播耐环丙沙星淋病奈瑟菌:历史教训。
J Antimicrob Chemother. 2019 Aug 1;74(8):2214-2219. doi: 10.1093/jac/dkz182.
5
Identification of Internationally Disseminated Ceftriaxone-Resistant Neisseria gonorrhoeae Strain FC428, China.鉴定具有国际传播性的耐头孢曲松淋病奈瑟菌 FC428 株,中国。
Emerg Infect Dis. 2019 Jul;25(7):1427-1429. doi: 10.3201/eid2507.190172. Epub 2019 Jul 17.
6
Cooperative Recognition of Internationally Disseminated Ceftriaxone-Resistant Neisseria gonorrhoeae Strain.合作识别国际传播的头孢曲松耐药淋病奈瑟菌菌株。
Emerg Infect Dis. 2018 Apr;24(4):735-40. doi: 10.3201/eid2404.171873.
7
The Molecular Epidemiology and Antimicrobial Resistance of Neisseria gonorrhoeae in Australia: A Nationwide Cross-Sectional Study, 2012.澳大利亚淋病奈瑟菌的分子流行病学和抗菌药物耐药性:2012 年全国性横断面研究。
Clin Infect Dis. 2016 Dec 15;63(12):1591-1598. doi: 10.1093/cid/ciw648. Epub 2016 Sep 28.
8
New Ceftriaxone- and Multidrug-Resistant Neisseria gonorrhoeae Strain with a Novel Mosaic penA Gene Isolated in Japan.在日本分离出携带新型嵌合penA基因的新型头孢曲松和多重耐药淋病奈瑟菌菌株。
Antimicrob Agents Chemother. 2016 Jun 20;60(7):4339-41. doi: 10.1128/AAC.00504-16. Print 2016 Jul.